Aciclovir for herpes simplex virus type 2 meningitis
Treatments studied
Part of Brain & nervous system, Infections clinical trials.
This study tests whether taking an antiviral medicine (aciclovir) by mouth can help people recover from meningitis caused by the herpes simplex virus type 2 (HSV-2). You would receive either the active medicine or a placebo (a pill with no active ingredient) to see if it improves recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have symptoms like headache, stiff neck, sensitivity to light, or fever, and you are suspected of having viral meningitis.
- A spinal tap (lumbar puncture) shows too many white blood cells in your spinal fluid, and a test confirms HSV-2 (herpes simplex virus type 2) is the cause.
- You are alert and fully conscious (scoring 15 on the Glasgow Coma Scale).
- You can swallow and absorb oral medications (tablets or capsules).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acyclovir, an antiviral drug, can help patients with pneumonia who are on breathing support and have herpes simplex virus in their lung fluid. The goal is to see if it improves recovery.
This trial tests whether giving the antiviral drug acyclovir early can help people on ventilators who show signs of herpes virus in the throat. The goal is to reduce complications and improve recovery.
This trial tests whether a medicine called acyclovir can prevent herpes simplex outbreaks in people who also have an autoimmune rheumatic disease. It may help reduce the number of painful cold sores or genital herpes episodes you experience.
This study checks how acyclovir behaves in the body when it’s given by mouth or through an IV to children receiving cancer care. It may help doctors better choose doses and monitor the medicine in kids who need prevention or treatment of certain viral infections.
This study tests a new mRNA vaccine designed to protect against herpes simplex virus type 2 (HSV-2), the virus that causes genital herpes. It is for healthy adults who have not had a genital herpes outbreak in the last 6 months.
This trial offers a new antiviral medicine called pritelivir to people with weakened immune systems who have herpes sores that do not get better with standard treatments. Taking pritelivir may help clear these resistant sores when other options have failed.
Hear when a new Herpes Simplex 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.